Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Pharma
Congress's biotech report, NIH ban, GSK-ABL—Fierce Pharma Asia
A congressional committee released a report on the U.S.-China biotech rivalry. The NIH blocked China's access to some databases. And more.
Angus Liu
Apr 11, 2025 10:31am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Incyte posts mixed Opzelura results in prurigo nodularis
Mar 10, 2025 11:23am
Incyte provides first guidance for JAK cream Opzelura
Feb 10, 2025 2:25pm
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
Incyte's Monjuvi proves its worth in follicular lymphoma
Nov 25, 2024 3:20pm
.jpg?VersionId=JZg8uabwrEWifelJJNt0HqM35XXgBoXj)